Monthly Archives: December 2018

Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System

AUDUBON, Pa., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS®, a revolutionary robotic guidance and navigation system, to the international market with system installations completed in several European countries. This past October, the first European Excelsius GPS® procedure was performed at the

By |2018-12-07T16:10:44+00:00December 7th, 2018|Robotics|
Read More

Kuros Reports Publication of MagnetOs Data Demonstrating Equivalence to Autologous Bone in Spinal Fusion

SCHLIEREN (ZURICH), Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) today announced the publication of data from a clinically-relevant preclinical model comparing MagnetOs with autologous bone in instrumented posterolateral spinal fusion in sheep. Utilizing multiple assessments for fusion, the study concluded that MagnetOs is a suitable alternative to autograft when used as

By |2018-12-06T17:36:31+00:00December 6th, 2018|Biologics|
Read More

IntraFuse Granted US Patent for FlexThread™ Intramedullary Fracture Fixation System

LOGAN, Utah, Dec. 6, 2018 /PRNewswire/ -- IntraFuse, a start-up medical device company operated by Surgical Frontiers, is focused on advanced surgical devices for improving outcomes for orthopedic extremity procedures, announced today that the United States Patent and Trademark Office has recently granted the company a key patent related to its FlexThread™ Intramedullary Fracture Fixation system. US Patent 10,136,929

By |2018-12-06T17:05:52+00:00December 6th, 2018|Regulatory, Top Stories|
Read More

Spine Biologics Market Share will Increase US $2.5 Billion by 2022

Dec 05, 2018 (Heraldkeeper via COMTEX) -- New York, December 05, 2018: The Global Spine Biologics Market is expected to exceed more than US$ 2.5 Billion by 2022, at a CAGR of 4.4% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in

By |2018-12-06T16:27:25+00:00December 6th, 2018|Biologics, Spine|
Read More

joimax® Rolls Out Its Endoscopic Generation 4 Devices and Showcases New 3D-Printed Titanium Implants at the German Spine Society (DWG) Convention

December 06, 2018 KARLSRUHE, Germany & IRVINE, Calif.--(BUSINESS WIRE)--joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is well positioned for Germany’s principal spine convention, German Spine Society (DWG), taking place December 6 to 8 in Wiesbaden, Germany. This year, joimax® is focusing on their Endoscopic Tower Generation 4 Devices, an

By |2018-12-06T15:50:12+00:00December 6th, 2018|Spine|
Read More

SpineGuard Announces a Partnership with Carnot Interfaces for the Combination of its DSG® Technology with Surgical Robots

December 05, 2018 PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that designs, develops, and markets disposable medical devices intended to make spine surgery safer by bringing real-time digital technology into the operating room, announced today a partnership agreement with Carnot Interfaces for the combination of its DSG technology with surgical

By |2018-12-06T15:28:46+00:00December 6th, 2018|Spine|
Read More

Jupiter Medical Center is the first hospital in the southeastern United States to use SpineJack®

Jupiter, Florida, Dec. 05, 2018 (GLOBE NEWSWIRE) -- JUPITER, FLORIDA (December 5, 2018) — Jupiter Medical Center is the first hospital in the southeastern United States to use SpineJack®, an implantable system that relieves the pain of acute vertebral compression fractures (VCFs), the most common fracture in patients with osteoporosis. The innovative device stabilizes and restores damaged

By |2018-12-05T17:15:53+00:00December 5th, 2018|Spine, Top Stories|
Read More

FX Shoulder USA, Inc. to Begin Clinical Study on Stemless Reversed Total Shoulder

DALLAS, December 5, 2018 /PRNewswire/ -- FX Shoulder USA, Inc. will begin in December 2018 the FDA approved Investigational Device Exemption (IDE) clinical study of the Easytech Reversed stemless, a shoulder prosthesis, with its first implantation scheduled for December. Easytech Reversed Stemless is an innovative shoulder arthroplasty implant that will be under clinical study with (9) sites and (12) surgeons

By |2018-12-05T16:25:12+00:00December 5th, 2018|Recon, Top Stories|
Read More

Hospitals sue over site-neutral payment policy

By Susannah Luthi  | December 4, 2018 The American Hospital Association on Tuesday led a lawsuit against the Trump administration over the CMS' final rule imposing a site-neutral payment policy, which cuts some Medicare rates for outpatient hospital sites to match the rates for physicians' offices. The lawsuit, filed in the U.S. District Court for the District of Columbia, challenges

By |2018-12-05T15:57:26+00:00December 5th, 2018|Regulatory|
Read More

Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend

December 04, 2018  Kalamazoo, Michigan, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on January 31, 2019 to shareholders of record at the close of business on December 31, 2018, representing

By |2018-12-04T22:55:34+00:00December 4th, 2018|Financial|
Read More
Odysseus Medical Solutions 2018
RssEmail